Navigation Links
TPI Business and Development Profile Updated on OneMedDatabase
Date:4/4/2011

CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has updated its corporate business & development information on OneMedDatabase, a division of OneMedPlace, a New York-based healthcare research and business & development firm.

The profile is to serve as a portal for TPI in the development of partnership with U.S. as well as international pharmaceutical companies for the further growth expansion via TPI's in-depth coverage of pharmaceutical sales network in China and TPI's upcoming macrolide antibiotic API business.

The updated profile of TPI along with an interview with the management can be found via the following link: http://www.onemedplace.com/database/list/cid/14315

About OneMedPlace

OneMedPlace (OMP), based in New York, is a healthcare research company that manages a business development platform to help emerging healthcare and life sciences companies maximize their potentials. OMP provides companies and investors with efficient access to information about potential opportunities around the world through an integrated set of tools including:

OneMedDatabase: Over 8,000 companies and resources.

OneMedForum: a biannual business development and investment conferences in San Francisco (January) and New York City (June).

OneMedTV: Documentaries on promising companies and technologies and important healthcare events.

Sentinel: weekly e-newsletter tracking the major healthcare industrial trends.

For more information regarding OneMedPlace, please visit: www.OneMedPlace.com

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. TPI currently manufactures a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

James Jiayuan Tong M.D. Ph.D.
Chief Financial Officer, Chief Business & Development Officer
Director
Tianyin Pharmaceutical Co., Inc.
Web:     http://www.tianyinpharma.com
Email:   Dr.Tong@tianyinpharma.com

Tel:  +86-28-8551-6696 (Chengdu, China)
       +86-134-3655-0011 (China)
       +1-949-350-6999 (U.S.)

Address:

23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kronos Announces First Quarter Business Update and Financial Results
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. ImaRx Therapeutics Transitions Business Strategy
4. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
5. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
6. Small Business Innovation Research Program Awards Grant to Biomoda
7. American Dairy Provides Business Update
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Pharmos Issues Business Update on Dextofisopam Trial and Financing
10. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Research and Markets has announced the addition of the "Global ... offering. ... global CINV drugs market to grow at a CAGR of 5.41% ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. To calculate the market ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... The report " Automated Breast Ultrasound System (ABUS) Market Size ... (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook (U.S., Canada ... Germany , UK, France , Spain ... China , Japan , India ... Saudi Arabia , UAE, South Africa ), Application Growth ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales ... market. , Over the past 20 years SFI has been recognized as the world’s ... six new clients into the US market. The new clients include: Panacea Pro, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the American Osteopathic College of Proctology) announced today the opening of 3 ... California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids ...
(Date:1/18/2017)... ... 2017 , ... From a health perspective, 2017 will clearly be the Year ... chronic disease, mental health and general physical well-being. The New York Times suggested a ... , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... leading journal and most-read publication among specialty pharmacists and pharmacy professionals, has ... its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of Pharmacy ...
(Date:1/18/2017)... ... 18, 2017 , ... The Portee Insurance Agency, a family managed firm that ... Maryland and the DC region, is inaugurating a charity event aimed at fighting heart ... making it the #1 killer in America. However, heart disease is largely preventable, and ...
Breaking Medicine News(10 mins):